Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial — P. Kosmidis (2000) | RDL Network
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial
P. Kosmidis, Nick Mylonakis, C. Nicolaides, C. Kalophonos, Epaminontas Samantas, J. Boukovinas, George Fountzilas, Dimosthenis Skarlos, T. Economopoulos, D. Tsavdaridis, Pavlos Papakostas, C. Bacoyiannis, Meletios A Dimopoulos
P. Kosmidis, Haralabos P. Kalofonos, K. Syrigos, D. Skarlos, George Fountzilas, C. Nicolaides, D. Bafaloukos, E. Samantas, C. Bakogiannis, Meletios A Dimopoulos
P. Kosmidis, Eleni Timotheadou, Αngelos Koutras, George Pentheroudakis, C. Christodoulou, Meletios A Dimopoulos, D. Bafaloukos, E. Samantas, Dimitrios Pectasides, K. Syrigos
P. Kosmidis, Haralabos P. Kalofonos, K. Syrigos, D. Skarlos, George Fountzilas, C. Nicolaides, D. Bafaloukos, E. Samantas, C. Bakogiannis, Meletios A Dimopoulos
P. Kosmidis, Konstantinos Syrigos, Haralabos P. Kalofonos, Meletios A Dimopoulos, Dimosthenis Skarlos, N Pavlidis, Ioannis Boukovinas, Dimitrios Bafaloukos, Dimitrios Pectasides, C. Bacoyiannis, George Fountzilas
Discussion(0)
No comments yet. Be the first to comment.